Table 1.

Characteristics of the ATTICA study’s participants (n = 2020) according to the 10-year fatal or non-fatal incidence of CVD

		Status at 10-year follow – up
	Baseline	CVD event free (n = 1703)	CVD events (n = 317)	p
Age, yrs	45 ± 14	43 ± 13	58 ± 13	<0.001
Male gender, %	50 %	48 %	63 %	<0.001
Years of school	12 ± 4	13 ± 4	10 ± 4	<0.001
Smoking at baseline or before, %	43 %	55 %	57 %	0.462
Physical activity, %	41 %	41 %	41 %	0.999
MedDietScore (0–55)	26 ± 7	26 ± 6	23 ± 7	<0.001
Hypertension, %	30 %	28 %	51 %	<0.001
Hypercholesterolemia, %	39 %	40 %	57 %	<0.001
Use of lipid-lowering meds, %	25 %	38 %	21 %	<0.001
Total cholesterol, mmol/L	4.99 ± 1.09	4.99 ± 1.06	5.33 ± 1.09	<0.001
HDL-cholesterol, mmol/L	1.24 ± 0.39	1.27 ± 0.39	1.16 ± 0.31	<0.001
LDL-cholesterol, mmol/L	3.15 ± 0.96	3.13 ± 0.96	3.39 ± 1.03	<0.001
Apolipoprotein AI, mg/dL	154 ± 27	156 ± 27	150 ± 24	0.001
Apolipoprotein B, mg/dL	108 ± 38	106 ± 42	109 ± 29	<0.001
Triglycerides, mmol/L**	1.13 ± 0.42	1.08 ± 0.41	1.48 ± 0.51	<0.001
Lipoprotein-a, mg/dL**	11 ± 9.5	11 ± 9.5	13 ± 11	0.052
Diabetes, %	7 %	5 %	22 %	<0.001
Obesity, %	18 %	17 %	28 %	<0.001
Family history of CVD, %	28 %	28 %	32 %	0.297

*p-values for the comparisons between CVD event and event-free group derived using the t-test for age, total, HDL-cholesterol and MedDietScore or Mann–Whitney non-parametric test (**) for years of school and the rest lipids, while for the comparisons of categorical variables using the chi-square test